| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/2005 | CA2530184A1 Method of selecting patients suitable for wt1 vaccine |
| 01/06/2005 | CA2529945A1 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | CA2529941A1 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | CA2529873A1 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | CA2529522A1 Methioninase treatment for p.carinii infection |
| 01/06/2005 | CA2528961A1 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | CA2528723A1 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | CA2528511A1 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | CA2528434A1 Combination therapy for b cell disorders |
| 01/06/2005 | CA2528146A1 An improved method and apparatus for dosing single and multi-agent therapy |
| 01/06/2005 | CA2528067A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | CA2527689A1 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | CA2526343A1 Ancestral viruses and vaccines |
| 01/06/2005 | CA2526085A1 Treatment with anti-vegf antibodies |
| 01/06/2005 | CA2526080A1 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 01/06/2005 | CA2526023A1 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | CA2525251A1 Cd20-specific antibodies and methods of employing same |
| 01/05/2005 | EP1493751A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 01/05/2005 | EP1493447A2 Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations |
| 01/05/2005 | EP1493445A1 Inhibition of stress-induced ligand-dependent EGFR activation |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492891A1 Methods of virus production |
| 01/05/2005 | EP1492885A2 Schizophrenia associated genes |
| 01/05/2005 | EP1492884A2 Methods of diagnosing and treating colorectal cancer |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/05/2005 | EP1492867A2 Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti |
| 01/05/2005 | EP1492819A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492814A2 Novel peptides and the application thereof in therapy |
| 01/05/2005 | EP1492808A2 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 01/05/2005 | EP1492566A2 Binding agents and their use in targeting tumor cells |
| 01/05/2005 | EP1492564A2 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492562A2 Virus-like particles of human papillomavirus |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492516A2 Use of mob-5 in pain |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1492402A2 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
| 01/05/2005 | EP1152773B1 Methods of inactivating pathogens using broad-spectrum pulsed light |
| 01/05/2005 | EP0996451B1 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 01/05/2005 | EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 01/05/2005 | EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 01/05/2005 | EP0699078B1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10326187A1 Zellen als Träger für Bakterien Cells as carriers for bacteria |
| 01/05/2005 | CN1561389A Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
| 01/05/2005 | CN1561230A Antigenic compositions |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561225A Modulation of leukocyte-endothelial interactions following ischemia |
| 01/05/2005 | CN1561218A Enteral compositions for the prevention and/or treatment of sepsis |
| 01/05/2005 | CN1560259A DNA vaccine carrier of carring SV40 enhancer element |
| 01/05/2005 | CN1560248A Tiantan remocined vaccine virus of IFN-alpha receptor gene (B8R) deletion and application thereof |
| 01/05/2005 | CN1560082A Chimeric antibod of antihumon recombined basicity fibroblast growth factor and construction and using thereof |
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1560078A Tumor antigen based on products of the tumor suppressor gene WT1 |
| 01/05/2005 | CN1560073A Analogy short peptide at growth factor antigen surface position of basicity fibroblast and its sieving and using |
| 01/05/2005 | CN1559611A Preparation of horse family animal anti human, pultry grippe immune globulin and its medicinal preparation |
| 01/05/2005 | CN1559610A Vaccine curing for disease and its preparation method |
| 01/05/2005 | CN1559607A Nucleic acid and protein composition and its production method and application in immune regulation |
| 01/05/2005 | CN1559441A Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183112C PEG-inerferon conjugate |
| 01/05/2005 | CN1182871C Vaccine against intra-cellular pathogens |
| 01/05/2005 | CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant |
| 01/04/2005 | US6838553 Peptide repeat immunogens |
| 01/04/2005 | US6838290 Detecting modulators of interleukin activity; obtain modulator, incubate with preferential cells, monitor interleukin response |
| 01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
| 01/04/2005 | US6838279 DNA having a deletion in both copies of the LAT gene and ICP34.5 gene are inserted into the malignant cell |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains |
| 01/04/2005 | US6838269 Comprises reduced allergenic variant of enzymatic polypeptide for use in textile treatment and cleaning composition and animal feeds; antiallergens |
| 01/04/2005 | US6838264 Antigenic peptide for inducing the formation of antibodies |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838258 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 01/04/2005 | US6838113 Increasing the digestibility of food proteins by thioredoxin reduction |
| 01/04/2005 | US6838089 Vaccines; immunogens; for Helicobacter infections |
| 01/04/2005 | US6838086 Comprises dendritic cells; for production of vaccines; anticancer agents |
| 01/04/2005 | US6838085 DNA immunization against Chlamydia infection |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | US6838081 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient |
| 01/04/2005 | US6838080 Mixture of a sialic acid binding compound and antigens |
| 01/04/2005 | CA2470262A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/04/2005 | CA2434685A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2434668A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 01/04/2005 | CA2144950C Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/30/2004 | US20040266719 immunostimulatory CpG oligonucleotide for inducing a mucosal immune response for treating a subject having an infection comprising enterovirus, calciviridae, vesicular stomatitis, rotavirus infection, Salmonella spp. infection, Helicobacter pyloris infection and M. intracellulare infection |
| 12/30/2004 | US20040266715 Neurite regeneration |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |